Vanguard's stake falling below 5% removes the requirement for future 13G filings, reducing transparency into their position. Monitor for any further insider selling or institutional trimming given the passive reduction.
Price Chart
Executive Summary
Vanguard Capital Management LLC filed an amended Schedule 13G disclosing a 4.82% passive stake in Pacira BioSciences as of September 30, 2026, down from a prior filing by Vanguard Group Inc. in March 2026. The stake is below the 5% threshold, indicating a reduction in Vanguard's aggregate position.
Key Financial Metrics
Key Facts
- Vanguard Capital Management LLC reported beneficial ownership of 1,923,614 shares of Pacira BioSciences common stock.
- The stake represents 4.82% of shares outstanding as of September 30, 2026.
- This is an amendment to a prior Schedule 13G; the filing certifies passive intent under Rule 13d-1(b).
- The stake is below the 5% threshold, representing a decrease from prior filings where Vanguard Group Inc. reported over 5%.
Financial Impact
Stake valued at approximately $92.6M based on market cap of $1.5B and 4.82% ownership.
Risk Factors
- Passive stake reduction by a major index fund may signal reduced institutional interest.
- Below 5% threshold means future changes in Vanguard's position will not be disclosed via 13G filings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0002100119-26-001682 |
| Document: 0002100119-26-001682-index.html | 0002100119-26-001682 |
| Document: 0002100119-26-001682.txt | 0002100119-26-001682 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | SC 13G/A | $36.40 | awaiting T+60 | awaiting T+60 | $36.39 (−0.03%) |
Oct 30, 2026 2d ago | SC 14D-9 | $36.39 | awaiting T+60 | awaiting T+60 | $36.39 (−0.00%) |
Oct 30, 2026 2d ago | SC TO-T | $36.39 | awaiting T+60 | awaiting T+60 | $36.39 (−0.00%) |
Oct 13, 2026 19d ago | SC 13D/A | $36.40 | awaiting T+60 | awaiting T+60 | $36.39 (+0.03%) |
Oct 8, 2026 24d ago | SC TO-C | $36.31 | awaiting T+60 | awaiting T+60 | $36.39 (+0.22%) |
Oct 8, 2026 24d ago | 144 | $36.39 | awaiting T+60 | awaiting T+60 | $36.39 (−0.00%) |
Oct 8, 2026 24d ago | 8-K | $36.39 | awaiting T+60 | awaiting T+60 | $36.39 (−0.00%) |
Oct 8, 2026 24d ago | SC TO-C | $36.39 | awaiting T+60 | awaiting T+60 | $36.39 (−0.00%) |
Aug 6, 2026 12w ago | Press Release | $25.58 $36.39 | ▲ +42.26% | ▲ +43.93% | $36.39 (+42.26%) |
Jul 22, 2026 14w ago | Press Release | $25.59 $36.33 | ▲ +41.97% | ▲ +38.71% | $36.39 (+42.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers